Since the initial description of sparse matrix crystallization screening by Jancarik and Kim in 1991 (which led to the development of Crystal Screen 1 and 2), many different screens for the crystallization of macromolecules have been developed(1). By our last count, there exist over 200 commercially available crystallization screens available from various companies, including approximately 50 screens available from Anatrace, Molecular Dimensions, and Microlytic. These include screens specific for the crystallization of nucleic acids, protein complexes, membrane proteins, kinases, and various other specific macromolecules.
|  |